Lexicon Pharmaceuticals, Inc. (LXRX)

Last Closing Price: 1.71 (2026-03-06)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Lexicon Pharmaceuticals, Inc. (LXRX) had Net Income of $-15.53M for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$5.49M
Net Income
$-15.53M
$0.20M
$5.29M
$20.27M
$-14.78M
$-0.75M
$-15.53M
$-15.53M
$-15.53M
$-15.53M
$-15.53M
$-15.53M
$-14.78M
$-14.17M
363.05M
363.05M
$-0.04
$-0.04
Balance Sheet Financials
$101.89M
$1.86M
$83.09M
$184.99M
$20.87M
$49.41M
$56.58M
$77.45M
$107.54M
$62.99M
$107.54M
365.85M
Cash Flow Statement Financials
$-67.85M
$113.02M
$-48.50M
$66.66M
$63.33M
$-3.33M
$12.52M
--
--
Fundamental Metrics & Ratios
4.88
--
--
0.31
0.50
96.34%
-269.09%
-269.09%
--
-282.71%
-282.71%
$-67.85M
--
--
--
0.03
0.72
2.30
39.06
-14.44%
-24.65%
-8.39%
-9.89%
$0.29
$-0.19
$-0.19